Just a moment…



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Repurposing drug shows promise in fighting aggressive brain tumors

Glioblastoma is the most common — and the most malignant — primary brain tumour in adults. It’s aggressive and incurable. Even with treatment including surgical removal and chemotherapy, the median

Novel drug molecule could help treat Parkinson’s disease in young patients

Activation of parkin by the tetrahydropyrazolo-pyrazine (THPP) BIO-2007817 in the presence of pUb. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-51889-3 More than 100,000 Canadians currently live with Parkinson’s disease. A novel

ALS: Blocking inflammation to reduce symptoms

In people with amyotrophic lateral sclerosis (ALS), changes in neurons appear to activate immune cells. Lowering the inflammation could reduce the symptoms of the disease, according to a study led